14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.47 $9.67 Friday, 3rd May 2024 ATNM stock ended at $8.96. This is 2.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.73% from a day low at $8.54 to a day high of $9.20.
90 days $5.08 $9.86
52 weeks $4.00 $9.86

Historical Actinium Pharmaceuticals, Inc prices

Date Open High Low Close Volume
May 03, 2024 $8.95 $9.20 $8.54 $8.96 519 062
May 02, 2024 $7.95 $8.81 $7.91 $8.75 679 660
May 01, 2024 $7.68 $7.96 $7.63 $7.78 215 007
Apr 30, 2024 $7.31 $7.98 $7.31 $7.70 273 324
Apr 29, 2024 $6.90 $7.48 $6.88 $7.38 243 935
Apr 26, 2024 $6.58 $6.92 $6.49 $6.87 202 694
Apr 25, 2024 $6.96 $6.97 $6.47 $6.56 322 605
Apr 24, 2024 $6.93 $7.31 $6.88 $7.06 151 964
Apr 23, 2024 $7.03 $7.43 $6.85 $6.96 185 216
Apr 22, 2024 $6.92 $7.34 $6.82 $7.17 189 863
Apr 19, 2024 $6.64 $7.01 $6.61 $6.85 342 658
Apr 18, 2024 $7.26 $7.51 $6.66 $6.67 414 837
Apr 17, 2024 $7.73 $7.82 $7.20 $7.25 294 950
Apr 16, 2024 $8.45 $8.45 $7.65 $7.74 366 480
Apr 15, 2024 $8.95 $9.10 $8.28 $8.44 253 610
Apr 12, 2024 $8.97 $9.04 $8.55 $9.00 302 341
Apr 11, 2024 $9.02 $9.28 $9.00 $9.09 454 537
Apr 10, 2024 $8.79 $9.14 $8.73 $8.99 341 099
Apr 09, 2024 $9.12 $9.13 $8.71 $8.98 343 851
Apr 08, 2024 $9.50 $9.67 $8.88 $9.13 430 213
Apr 05, 2024 $9.03 $9.57 $8.84 $9.54 484 615
Apr 04, 2024 $8.99 $9.36 $8.96 $9.13 386 351
Apr 03, 2024 $8.53 $9.22 $8.53 $8.84 400 114
Apr 02, 2024 $8.37 $8.78 $8.30 $8.60 284 581
Apr 01, 2024 $7.83 $8.74 $7.70 $8.56 627 310
Click to get the best stock tips daily for free!

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19... ATNM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT